These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

59 related articles for article (PubMed ID: 604122)

  • 21. Neuraminidase antibody response to inactivated influenza virus vaccine following intranasal and intramuscular vaccination.
    Muhamed G; Greenbaum E; Zakay-Rones Z
    Isr Med Assoc J; 2006 Mar; 8(3):155-8. PubMed ID: 16599048
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Failure of protection and enhanced pneumonia with a US H1N2 swine influenza virus in pigs vaccinated with an inactivated classical swine H1N1 vaccine.
    Vincent AL; Lager KM; Janke BH; Gramer MR; Richt JA
    Vet Microbiol; 2008 Jan; 126(4):310-23. PubMed ID: 17719188
    [TBL] [Abstract][Full Text] [Related]  

  • 23. [Formation and persistence of antibodies against envelope antigens of influenza virus after vaccination by formolized monovaccine (author's transl)].
    Stumpa A; Bruj J; Tůmová B; Skocil V
    Cesk Epidemiol Mikrobiol Imunol; 1978 Feb; 27(1):29-37. PubMed ID: 149598
    [No Abstract]   [Full Text] [Related]  

  • 24. [Testing of influenza virus vaccines--an international comparison].
    Klett G; Stäber H; Willkommen H
    Z Gesamte Hyg; 1980; 26(7):473-86. PubMed ID: 7003931
    [No Abstract]   [Full Text] [Related]  

  • 25. Standardization of inactivated H5N2 influenza vaccine and efficacy against lethal A/Chicken/Pennsylvania/1370/83 infection.
    Wood JM; Kawaoka Y; Newberry LA; Bordwell E; Webster RG
    Avian Dis; 1985; 29(3):867-72. PubMed ID: 4074253
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Seed viruses containing novel avian HA and NA antigens for prevention against potential influenza pandemic.
    Li S; Perdue ML; Patzer E
    Dev Biol (Basel); 2002; 110():135-41. PubMed ID: 12477316
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Protection of mice against lethal infection with highly pathogenic H7N7 influenza A virus by using a recombinant low-pathogenicity vaccine strain.
    de Wit E; Munster VJ; Spronken MI; Bestebroer TM; Baas C; Beyer WE; Rimmelzwaan GF; Osterhaus AD; Fouchier RA
    J Virol; 2005 Oct; 79(19):12401-7. PubMed ID: 16160167
    [TBL] [Abstract][Full Text] [Related]  

  • 28. A protective immune response in mice to viral components other than hemagglutinin in a live influenza A virus vaccine model.
    Horimoto T; Takada A; Iwatsuki-Horimoto K; Kawaoka Y
    Vaccine; 2004 Jun; 22(17-18):2244-7. PubMed ID: 15149783
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Antibody response in four animal species to two different influenza A/swine viruses.
    Dolezalová B; Závadová H; Stárek M; Vonka V
    J Biol Stand; 1978 Jul; 6(3):165-71. PubMed ID: 721835
    [No Abstract]   [Full Text] [Related]  

  • 30. Preparation and immunogenicity of an influenza virus hemagglutinin and neuraminidase subunit vaccine.
    Laver WG; Webster RG
    Virology; 1976 Feb; 69(2):511-22. PubMed ID: 1258359
    [No Abstract]   [Full Text] [Related]  

  • 31. Isolation of biologically active components from rabies and other envelope viruses.
    van der Marel P; van Wezel AL
    Dev Biol Stand; 1979; 42():93-8. PubMed ID: 467803
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Preparation-conditioned changes of the antigenicity of influenza virus neuraminidases.
    Desselberger U
    Arch Virol; 1977; 53(4):335-49. PubMed ID: 68766
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Standardization of assays of neuraminidase and its antibody.
    Bevan AM; Stones PB
    Dev Biol Stand; 1977 Jun 1-3; 39():485-8. PubMed ID: 75119
    [TBL] [Abstract][Full Text] [Related]  

  • 34. [Immunogenicity of recombinant influenza virus vaccines (author's transl)].
    Higashihara M; Suzuki Y; Saito Y; Igarashi Y; Yoshioka I; Takahashi M; Miki Y
    Uirusu; 1979 Dec; 29(2):127-39. PubMed ID: 550564
    [No Abstract]   [Full Text] [Related]  

  • 35. Preparation and properties of a novel influenza subunit vaccine.
    Bachmayer H; Liehl E; Schmidt G
    Postgrad Med J; 1976 Jun; 52(608):360-7. PubMed ID: 959116
    [TBL] [Abstract][Full Text] [Related]  

  • 36. The serological response of experimental animals to inactivated whole and split influenza virus vaccines.
    Fenton RJ; Jennings R; Potter CW
    J Biol Stand; 1977; 5(3):217-29. PubMed ID: 893466
    [No Abstract]   [Full Text] [Related]  

  • 37. Comparison of antibody titers in rabbits following immunization with inactivated influenza virus via subarachnoidal or subcutaneous route.
    Shin JH; Sakoda Y; Kim JH; Ochiai K; Umemura T
    J Vet Med Sci; 2007 Nov; 69(11):1167-9. PubMed ID: 18057832
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Hemagglutinin and neuraminidase specific cell-mediated immune responses to influenza A virus following immunization in guinea pigs.
    Chow TC; Beutner KR; Ogra PL
    Immunol Commun; 1980; 9(1):33-53. PubMed ID: 6154010
    [TBL] [Abstract][Full Text] [Related]  

  • 39. [Safety and effectiveness study of the aerosol method of administering inactivated influenza chromatographic vaccine in an experiment].
    Bichurina MA; Briantseva EA; Rozaeva NR; Titova TS; Korovina GI
    Vopr Virusol; 1984; 29(5):527-30. PubMed ID: 6516324
    [TBL] [Abstract][Full Text] [Related]  

  • 40. [Determination of the neuraminidase specificity of influenza A and B viruses using a modified lectin test].
    Liubovtseva OV; Zakstel'skaia LIa; Ivanova VT; Oskerko TA
    Vopr Virusol; 1983; 28(6):663-8. PubMed ID: 6199899
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 3.